Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.20M | 9.56M | 9.19M | 9.07M | 8.92M |
| Depreciation & Amortization | 500.10K | 490.50K | 499.90K | 525.90K | 1.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.28M | 16.14M | 11.46M | 10.59M | 12.13M |
| Operating Income | -17.28M | -16.14M | -11.46M | -10.59M | -12.13M |
| Income Before Tax | -21.56M | -14.92M | -11.11M | -8.23M | -10.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.56 | -14.92 | -11.11 | -8.23 | -10.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 688.00K | 712.90K | 873.90K | 757.10K | 516.50K |
| Net Income | -20.88M | -14.20M | -10.24M | -7.47M | -9.85M |
| EBIT | -17.28M | -16.14M | -11.46M | -10.59M | -12.13M |
| EBITDA | -16.78M | -15.65M | -10.96M | -10.06M | -10.63M |
| EPS Basic | -15.19 | -14.85 | -14.45 | -12.03 | -16.28 |
| Normalized Basic EPS | -9.52 | -9.15 | -8.18 | -8.78 | -10.52 |
| EPS Diluted | -15.19 | -14.85 | -14.45 | -12.03 | -16.28 |
| Normalized Diluted EPS | -9.52 | -9.15 | -8.18 | -8.78 | -10.52 |
| Average Basic Shares Outstanding | 6.02M | 4.15M | 2.77M | 2.46M | 2.42M |
| Average Diluted Shares Outstanding | 6.02M | 4.15M | 2.77M | 2.46M | 2.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |